Premarin (Conjugated Estrogens) - Adverse Event Reports - Serious Event - Breast Cancer Female

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-10-25

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Provera
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2004-11-01

Medroxyprogesterone Acetate
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2004-11-01

Estratest
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2004-11-01

Cycrin
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2004-11-01

Premarin
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2004-11-01

Prempro
    Indication: Hormone Replacement Therapy
    Start date: 1989-01-01
    End date: 2004-11-01

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-10-23

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone
    Dosage: oral
    Administration route: Oral
    Start date: 1996-01-01
    End date: 2004-11-01

Cycrin
    Dosage: oral
    Administration route: Oral
    Start date: 1989-01-01
    End date: 2004-11-01

Estratest
    Dosage: oral
    Administration route: Oral
    Start date: 1989-01-01
    End date: 2004-11-01

Premarin
    Dosage: oral
    Administration route: Oral
    Start date: 1989-01-01
    End date: 2004-11-01

Prempro
    Dosage: oral
    Administration route: Oral
    Start date: 1989-01-01
    End date: 2004-11-01

Provera
    Dosage: oral
    Administration route: Oral
    Start date: 1989-01-01
    End date: 2004-11-01

Adverse event in 56 year old female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-10-22

Patient: 56 year old female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone Acetate
    Dosage: oral
    Administration route: Oral
    Start date: 1997-01-01
    End date: 1998-01-01

Premarin
    Dosage: oral
    Administration route: Oral
    Start date: 1997-01-01
    End date: 1998-01-01

Prempro
    Dosage: oral
    Administration route: Oral
    Start date: 1998-01-01
    End date: 2002-01-01

Provera
    Dosage: oral
    Administration route: Oral
    Start date: 1997-01-01
    End date: 1998-01-01

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-10-18

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone Acetate
    Dosage: oral
    Administration route: Oral
    Start date: 1994-01-01
    End date: 2001-11-01

Premarin
    Dosage: oral
    Administration route: Oral
    Start date: 1994-01-01
    End date: 2001-11-01

Prempro
    Dosage: oral
    Administration route: Oral
    Start date: 1994-01-01
    End date: 2001-11-01

Provera
    Dosage: oral
    Administration route: Oral
    Start date: 1994-01-01
    End date: 2001-11-01

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-10-18

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone
    Dosage: oral
    Administration route: Oral
    Start date: 1998-01-01
    End date: 2001-12-01

Premarin
    Dosage: oral
    Administration route: Oral
    Start date: 1998-01-01
    End date: 2001-12-01

Prempro
    Dosage: oral
    Administration route: Oral
    Start date: 1998-01-01
    End date: 2001-12-01

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-10-18

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Provera
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1994-01-01
    End date: 2001-11-01

Medroxyprogesterone Acetate
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1994-01-01
    End date: 2001-11-01

Premarin
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1994-01-01
    End date: 2001-11-01

Prempro
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1994-01-01
    End date: 2001-11-01

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-10-12

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Provera
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1987-01-01
    End date: 2001-10-01

Medroxyprogesterone Acetate
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1987-01-01
    End date: 2001-10-01

Premarin
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1987-01-01
    End date: 2001-10-01

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-10-11

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Provera
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1999-01-01
    End date: 2001-02-01

Medroxyprogesterone Acetate
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1999-01-01
    End date: 2001-02-01

Premarin
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1999-01-01
    End date: 2001-02-01

Prempro
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1999-01-01
    End date: 2001-02-01

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-05

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone
    Dosage: oral
    Administration route: Oral
    Start date: 1987-01-01
    End date: 2001-10-01

Premarin
    Dosage: oral
    Administration route: Oral
    Start date: 1987-01-01
    End date: 2001-10-01

Provera
    Dosage: oral
    Administration route: Oral
    Start date: 1987-01-01
    End date: 2001-10-01

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-10-05

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic, Breast Cancer Female, Metastases TO Lymph Nodes

Suspect drug(s):
Prempro
    Indication: Hormone Replacement Therapy

Provera
    Indication: Hormone Replacement Therapy

Premarin
    Indication: Hormone Replacement Therapy

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-07-31

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Adverse event resulted in: death

Suspect drug(s):
Provera
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 1995-01-01
    End date: 2000-01-01

Premarin
    Indication: Menopausal Symptoms
    Start date: 1995-01-01
    End date: 2000-01-01

Estratest
    Indication: Menopausal Symptoms
    Start date: 1995-01-01
    End date: 2000-01-01

Estrace
    Indication: Menopausal Symptoms
    Start date: 1995-01-01
    End date: 2000-01-01

Adverse event in 70 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-07-23

Patient: 70 year old female, weighing 68.0 kg (149.7 pounds)

Adverse reactions / side effects: Biopsy Breast Abnormal, Blood Triglycerides Increased, Breast Cancer in Situ, Biopsy Breast Normal, Breast Cancer Recurrent, Carpal Tunnel Decompression, Breast Cyst, Hot Flush, Fibrocystic Breast Disease, Blood Cholesterol Increased, Papilloma, Lymphadenectomy, Bone Density Decreased, Benign Breast Neoplasm, Spinal Laminectomy, Intervertebral Disc Protrusion, Type 2 Diabetes Mellitus, Radiotherapy, Breast Mass, Breast Cancer Female, Osteopenia, Glucose Tolerance Impaired, Intervertebral Disc Space Narrowing, Bone Densitometry, Mastectomy

Suspect drug(s):
Estraderm
    Dosage: 0.1 mg 1 patch 2x per week
    Indication: Menopausal Symptoms
    Start date: 1987-07-01
    End date: 2001-07-01

Premarin
    Dosage: unk, unk
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 1977-09-01
    End date: 1987-07-01

Provera
    Dosage: 10 mg cyclic
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 1976-06-01
    End date: 1976-10-01

Other drugs received by patient: Fosamax Once Weekly

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-07-11

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Provera
    Administration route: Oral
    Indication: Hormone Replacement Therapy

Medroxyprogesterone Acetate
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1994-06-01

Premarin
    Indication: Hormone Replacement Therapy

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-07-11

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Provera
    Administration route: Oral
    Indication: Hormone Replacement Therapy

Medroxyprogesterone Acetate
    Administration route: Oral
    Indication: Hormone Replacement Therapy

Premarin
    Indication: Hormone Replacement Therapy
    Start date: 1963-01-01

Prempro
    Indication: Hormone Replacement Therapy

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-07-06

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone Acetate
    Dosage: oral
    Administration route: Oral

Estradiol
    Dosage: oral
    Administration route: Oral

Cycrin
    Dosage: oral
    Administration route: Oral

Estratest
    Dosage: oral
    Administration route: Oral

Premarin
    Dosage: oral
    Administration route: Oral

Prempro
    Dosage: oral
    Administration route: Oral

Adverse event in 63 year old female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-07-05

Patient: 63 year old female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone
    Dosage: oral
    Administration route: Oral
    Start date: 1992-01-01
    End date: 1999-01-05

Premarin
    Dosage: 1.25 mg, oral
    Administration route: Oral
    Start date: 1992-01-01
    End date: 1999-01-05

Provera
    Dosage: 10 mg, oral
    Administration route: Oral
    Start date: 1992-01-01
    End date: 1999-01-05

Prempro
    Dosage: oral
    Administration route: Oral
    Start date: 1999-01-06
    End date: 2002-09-01

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-07-05

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Provera
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1995-01-01
    End date: 2004-01-01

Medroxyprogesterone Acetate
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1995-01-01
    End date: 2004-01-01

Estradiol
    Indication: Hormone Replacement Therapy
    Start date: 1995-01-01
    End date: 2004-01-01

Premarin
    Indication: Hormone Replacement Therapy
    Start date: 1995-01-01
    End date: 2004-01-01

Prempro
    Indication: Hormone Replacement Therapy
    Start date: 1995-01-01
    End date: 2004-01-01

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-06-27

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone Acetate
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1999-01-01
    End date: 2003-03-01

Premarin
    Indication: Hormone Replacement Therapy
    Start date: 1999-01-01
    End date: 2003-03-01

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-06-26

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone Acetate
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1995-01-01
    End date: 2001-04-01

Premarin
    Indication: Hormone Replacement Therapy
    Start date: 1995-01-01
    End date: 2001-04-01

Prempro
    Indication: Hormone Replacement Therapy
    Start date: 1995-01-01
    End date: 2001-04-01

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-06-12

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone
    Dosage: oral
    Administration route: Oral

Premarin
    Dosage: oral
    Administration route: Oral

Prempro
    Dosage: oral
    Administration route: Oral

Provera
    Dosage: oral
    Administration route: Oral

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-06-12

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone
    Dosage: oral
    Administration route: Oral

Premarin
    Dosage: oral
    Administration route: Oral

Prempro
    Dosage: oral
    Administration route: Oral

Provera
    Dosage: oral
    Administration route: Oral

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-06-12

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone Acetate(medroxyprogesterone Acetate(medroxyprogest
    Dosage: oral
    Administration route: Oral

Estradiol
    Dosage: oral
    Administration route: Oral

Cycrin
    Dosage: oral
    Administration route: Oral

Estrace
    Dosage: oral
    Administration route: Oral

Estratest
    Dosage: oral
    Administration route: Oral

Premarin
    Dosage: oral
    Administration route: Oral

Prempro
    Dosage: oral
    Administration route: Oral

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-06-04

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Provera
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1990-01-01
    End date: 2001-12-01

Medroxyprogesterone Acetate
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1990-01-01
    End date: 2001-12-01

Premarin
    Indication: Hormone Replacement Therapy
    Start date: 1990-01-01
    End date: 2001-12-01

Prempro
    Indication: Hormone Replacement Therapy
    Start date: 1990-01-01
    End date: 2001-12-01

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-06-01

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Medroxyprogesterone Acetate
    Dosage: oral
    Administration route: Oral
    Start date: 1990-01-01
    End date: 2001-12-01

Premarin
    Dosage: oral
    Administration route: Oral
    Start date: 1990-01-01
    End date: 2001-12-01

Prempro
    Dosage: oral
    Administration route: Oral
    Start date: 1990-01-01
    End date: 2001-12-01

Provera
    Dosage: oral
    Administration route: Oral
    Start date: 1990-01-01
    End date: 2001-12-01

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-05-23

Patient: female

Adverse reactions / side effects: Breast Cancer Female

Suspect drug(s):
Provera
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1994-01-01
    End date: 2002-01-01

Medroxyprogesterone Acetate
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1994-01-01
    End date: 2002-01-01

Cycrin
    Indication: Hormone Replacement Therapy
    Start date: 1994-01-01
    End date: 2002-01-01

Premarin
    Indication: Hormone Replacement Therapy
    Start date: 1994-01-01
    End date: 2002-01-01